Treating Blood Cancers The Leukemia & Lymphoma Society

David Dean, DDS, MSD, DABOM, FDS RCSEd, Fred Hutchinson Cancer Center and University of Washington School of Dentistry, Seattle, WA

























Recorded on April 25, 2024











David Dean, DDS, MSD, DABOM, FDS RCSEd

Director, Oral Medicine

Fred Hutchinson Cancer Center

Clinical Associate Professor

University of Washington School of Dentistry

Seattle, WA









Join us, as Dr. David Dean from Fred Hutchinson Cancer Center and the University of Washington School of Dentistry uncovers essential aspects of oral health in cancer care, including symptoms that may indicate a blood cancer, common dental complications that arise from treatment, and insights into preventative care. Dr. Dean also addresses special considerations for patients with cancer needing dental care and strategies for healthcare providers to provide optimal support for patients navigating dental challenges. Tune in to learn more today!

Cesar Rodriguez, MD, Mount Sinai Hospital, New York, NY

























Recorded on April 16, 2024











Cesar Rodriguez, MD

Associate Professor of Medicine, Tisch Cancer Institute

Clinical Director, Multiple Myeloma Center of Excellence

Mount Sinai Hospital

New York, NY









Join us for an insightful episode with Dr. Cesar Rodriguez from Mount Sinai Hospital as he discusses the healthcare provider’s role in survivorship care for older adults. Dr. Rodriguez explores the unique challenges of managing long-term and late effects of treatment and coordinating follow-up care. He also shares valuable perspectives on the impact of language and cultural considerations, along with the importance of caregiver support for older adult survivors. Listen in today!













This episode is supported by Genentech, Inc. & Biogen and Merck & Co., Inc.

Karen E. Effinger, MD, MS, Children’s Healthcare of Atlanta, Atlanta, GA

























Recorded on April 4, 2024











Karen E. Effinger, MD, MS

Associate Professor of Pediatrics

Emory University School of Medicine

Co-Director, Survivor Program

Aflac Cancer & Blood Disorders Center, Children’s Healthcare of Atlanta

Atlanta, GA









In this episode, Dr. Karen Effinger from Children’s Healthcare of Atlanta, provides a comprehensive overview into survivorship care for pediatric, adolescent, and young adult (AYA) patients. Dr. Effinger discusses long-term effects of treatment, importance of survivorship guidelines, survivorship care plans, and ongoing care management. She also addresses approaches to support survivors and their families to underscore the vital role in optimizing outcomes. Tune in today to hear valuable insights into supporting pediatric and AYA survivors!













This episode is supported by Genentech, Inc. & Biogen and Merck & Co., Inc.

Hagop M. Kantarjian, M.D., MD Anderson Cancer Center, Houston, TX

























Recorded on March 28, 2024











Hagop M. Kantarjian, M.D.

Professor and Chairman, Department of Leukemia

Samsung Distinguished University Chair in Cancer Medicine

MD Anderson Cancer Center, University of Texas

Houston, TX









Join us for this episode as Dr. Hagop Kantarjian from MD Anderson Cancer Center discusses the latest advancements and progress in treating Acute Myeloid Leukemia (AML). From understanding genetic mutations to exploring emerging treatment options, Dr. Kantarjian shares valuable insights into the forefront of AML research and care.

Learn more today!

Michael Tees, MD, MPH, Colorado Blood Cancer Institute, Denver, CO

























Recorded on March 12, 2024











Michael Tees, MD, MPH

Director, Lymphoma Program

Lymphoma Executive Committee Member, Sarah Cannon Research Institute

Associate Member, Colorado Blood Cancer Institute

Denver, CO









Join Dr. Michael Tees from the Colorado Blood Cancer Institute, as he discusses

Chimeric antigen receptor (CAR) T-cell therapy in 2024. Dr. Tees provides an overview of immunotherapy and approved indications, how to discuss treatment options with your patients, what to consider when referring patients for CAR T-cell therapy, how to prepare patients, and educating patients and caregivers about toxicity management. He also provides insight into the limitations of CAR-T therapy, as well as future directions. Tune in to this informative episode today to learn more!













This episode is supported by Bristol Myers Squibb, Johnson & Johnson|Legend Biotech, Kite, a Gilead Company, and Novartis Pharmaceuticals Corporation.

Alfred Lee, MD, PhD, Yale University, New Haven, CT

























Recorded on February 22, 2024











Alfred Lee, MD, PhD

Professor of Medicine, Yale School of Medicine

Program Director, Hematology and Medical Oncology Fellowship

Chief, Division of Classical Hematology, Yale Cancer Center

Yale University

New Haven, CT









Join us for this important and engaging episode, as Dr. Alfred Lee from Yale University addresses stress and burnout in healthcare professionals. While reflecting on his personal experience, Dr. Lee discusses warning signs, symptoms, risk factors, and strategies and resources to help reduce and prevent burnout. Tune in today!